SABCS
UK Study Details Liquid Biopsy's Ability to Guide Metastatic Breast Cancer Treatment
The researchers used the Guardant360 assay and droplet digital PCR to identify genetic mutations in circulating tumor DNA that had been shed into the patients' bloodstream.
SABCS 2018 Features Molecular Diagnostics Research
At the conference, researchers presented data from a number of studies using molecular diagnostic tools to better characterize breast cancer recurrence and treatment outcomes.
Myriad Genetics Describes Advancement of Hispanic-Specific Breast Cancer Polygenic Risk Score
Premium
The studies involved data from 14,000 Hispanic women and showed the 87-SNP risk score outperformed its 86-SNP score for European women.
Myriad Genetics Breast Cancer Risk SNP Score Improves Upon Traditional Measures, Study Shows
Premium
At the San Antonio Breast Cancer Symposium, Myriad reported on the ability of its 86 SNP score to predict disease risk for the majority of women of European ancestry.
Grade 3 breast tumors generally have worse prognoses, but SEER data showed that Oncotype DX can identify a large proportion of patients who do well without chemo.